Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy-Reference-Cited by-同舟云学术

Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy

Published:2011-03 Issue:3 Volume:138 Page:255-265
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Yamasaki Kazuki,Horiguchi Shigetoshi,Kurosaki Motoyoshi,Kunii Naoki,Nagato Kaoru,Hanaoka Hideki,Shimizu Naomi,Ueno Naoyuki,Yamamoto Seiji,Taniguchi Masaru,Motohashi Shinichiro,Nakayama Toshinori,Okamoto Yoshitaka

Funder

Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment)

MEXT (Japan)

Ministry of Education, Culture, Sports, Science and Technology (Japan)

Ministry of Health, Labor and Welfare (Japan)

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference26 articles.

1. The use of dendritic cells in cancer immunotherapy;Schuler;Curr. Opin. Immunol.,2003

2. The regulatory role of Vα14 NKT cells in innate and acquired immune response;Taniguchi;Annu. Rev. Immunol.,2003

3. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids;Porcelli;Annu. Rev. Immunol.,1999

4. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides;Kawano;Science,1997

5. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution;Brossay;J. Exp. Med.,1998

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive model to better screen out antiviral treatment candidates for chronic hepatitis B patients;International Immunopharmacology;2024-10

2. Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy;Frontiers in Immunology;2024-08-19

3. Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancer;Proceedings of the National Academy of Sciences;2024-07-09

4. Research progress of cell membrane biomimetic nanoparticles for circulating tumor cells;Frontiers in Oncology;2024-04-30

5. CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy;Frontiers in Immunology;2024-04-11